Yolanda Loo, MD | |
8201 164th Ave Ne, Suite #200 Pmb 164, Redmond, WA 98052-3862 | |
(425) 998-7431 | |
(855) 781-3064 |
Full Name | Yolanda Loo |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 8201 164th Ave Ne, Redmond, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033316450 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD60105385 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Yolanda Loo, MD 8201 164th Ave Ne, Suite #200 Pmb 164, Redmond, WA 98052-7615 Ph: (425) 998-7431 | Yolanda Loo, MD 8201 164th Ave Ne, Suite #200 Pmb 164, Redmond, WA 98052-3862 Ph: (425) 998-7431 |
News Archive
Prominent cardiac researchers will meet at San Diego State University in November to explore bold new approaches to treating the number one threat to U.S. adults - heart disease.
Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.
The research suggests that GPs are still managing individual risk factors such as blood pressure and cholesterol in isolation of one another, and are not adopting recommendations to treat a patient's overall or absolute risk. Absolute risk management is based on the principle that the major risk factors for cardiovascular disease act together. By taking this approach treatment can be targeted to those most likely to benefit.
Emerging Healthcare Solutions, Inc. announced today that it has acquired a Rotary Cell Culture System, or bioreactor, developed using revolutionary NASA research in the field of microgravity.
Cancer cells are notorious for their camouflage work, which enables them to escape immune targeting. Now scientists are learning how to strip away the disguise and allow the immune system to do its work, by targeting cells called myeloid-derived suppressor cells (MDSCs) that shield the tumor. This would also enhance the effectiveness of newer cancer immunotherapies like Chimeric-Antigen Receptor T cell (CAR-T).
› Verified 3 days ago
Dr. Alexis Hallock, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8250 165th Ave Ne, Suite 210, Redmond, WA 98052 Phone: 206-949-7371 | |
Dr. Suzanne Ballew Canning, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7810 Brown St, Ste 203, Redmond, WA 98052 Phone: 425-556-9306 Fax: 425-556-0999 | |
Rachel Jordan Betts, PA-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8980 161st Ave Ne Ste 400, Redmond, WA 98052 Phone: 425-899-2273 | |
Nana Aba Nduom, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 16771 Ne 80th St Ste 108, Redmond, WA 98052 Phone: 425-414-8799 Fax: 425-217-2427 | |
Brian Dean Jaeger, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 8301 161st Ave Ne Ste 300, Redmond, WA 98052 Phone: 425-885-3330 Fax: 425-702-2474 | |
Dr. Arjun Animesh Bansal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8301 161st Ave Ne Ste 204, Redmond, WA 98052 Phone: 425-881-5431 Fax: 425-881-8746 |